Open access · OA
via OpenAlex
Impact of Sodium Bicarbonate Supplementation on Serum Alpha Klotho in Chronic Kidney Disease Patients
Authors not listed
The Egyptian Journal of Hospital Medicine · 2024
Abstract
Background: The course of chronic kidney disease (CKD) is highly connected with the Klotho gene through multiple pathways, including renal fibrosis, vascular calcification, inflammation, and mineral bone abnormalities. Objectives: This study aimed to assess the impact of oral sodium bicarbonate supplementation on blood levels of soluble α-Klotho in patients suffering from chronic renal disease (stage 3b:4) at Ain Shams Specialized Hospital in Cairo, Egypt, using the CKD-EPI formula. Patients and Methods: 45 CKD patients were recruited for this interventional, prospective, open-label clinical trial from the Inpatient and Outpatient Clinics at Ain Shams Specialized Hospital in Cairo, Egypt. Results: The cohort study had an average age of 48.13 ± 6.96 years. Serum bicarbonate (HCO3) improved from mean 19.74 ± 1.43 mmol/L pre-study to 23.63 ± 3.23 mmol/L post-study, with a p-value of 0.000. Additionally, eGFR significantly improved with a p-value of 0.000 following the study. Serum alpha Klotho level was 596.30 ± 148.58 pg/mL before the study and 696.16 ± 172.99 pg/mL after the study, with a statistically significant difference of 0.006. Serum alpha Klotho after the study did not show a statistically significant link with serum creatinine, eGFR, potassium and phosphorus, or parathyroid. However, serum bicarbonate level and serum Klotho after the study showed a statistically significant positive correlation. Conclusion: Serumsoluble α klotho level was significantly higher post-study compared to pre-study after oral sodium bicarbonate supplementation and improved acidosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21608/ejhm.2024.344181
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2024). Impact of Sodium Bicarbonate Supplementation on Serum Alpha Klotho in Chronic Kidney Disease Patients. <em>The Egyptian Journal of Hospital Medicine</em>. https://doi.org/10.21608/ejhm.2024.344181
Vancouver
Anonymous. Impact of Sodium Bicarbonate Supplementation on Serum Alpha Klotho in Chronic Kidney Disease Patients. The Egyptian Journal of Hospital Medicine. 2024. doi:10.21608/ejhm.2024.344181.
BibTeX
@article{anon2024Impact,
title = {Impact of Sodium Bicarbonate Supplementation on Serum Alpha Klotho in Chronic Kidney Disease Patients},
author = {Anonymous},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2024},
doi = {10.21608/ejhm.2024.344181},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Medical science monitor basic research/Medical science monitor. Basic research 2023
Open access · CC-BY
Urinary Klotho Excretion: A Key Regulator of Sodium Homeostasis in Chronic Kidney Disease Stage 2-4
BMC Nephrology 2018
Open access · CC-BY
The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
The Medical Journal of Cairo University/The Medical Journal of Cairo University 2019
Open access · OA
Soluble Alpha Klotho Serum Level in Chronic Kidney Disease
Journal of Renal Nutrition 2014
Citation only
In Chronic Kidney Disease, Serum α-Klotho is Related to Serum Bicarbonate and Proteinuria
BMC Veterinary Research 2020
Open access · CC-BY
Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease
BMC Nephrology 2012
Open access · CC-BY